Dec 22 2022

george

Non-severe Hemophilia Treatment

Here is a meta-analysis of concentrate treatment for mild to moderate hemophilia. Iorio A, Königs C, Reding MT, et al. Prophylaxis use of clotting factor replacement products in people with non-severe haemophilia: A review of the literature. Haemophilia. 2022. doi: 10.1111/hae.14676.

read more

Comments (0)

Bleeding Disorders

Dec 7 2022

george

Hemosonics Quantra QStat Cartridge

On November 30, Hemosonics, LLC announced that they had received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the Quantra Hemostasis System with QStat cartridge, which accompanies their QPlus cartridge. Click here for the press release.

read more

Comments (0)

Viscoelastometry

Nov 30 2022

george

December, 2022 Cheat Sheet

Hello, Fritsma Factor participants. Here is your December 2022 Cheat Sheet. If you are on our Cheat Sheet subscriber list, you will receive your personal copy in a few days, and if you would like to subscribe, navigate to the bottom of our “Posts” page to provide your contact information. Again, thank you for your […]

read more

Comments (0)

Cheat Sheets

Nov 30 2022

george

December, 2022 Quick Question: Thrombosis Risk Profiles

I’ve been reviewing Choosing Wisely recommendations and Medscape discussions on the importance of assays for congenital thrombosis risk factors such as antithrombin, protein S, and protein C.  We’d like to know what comprises our profiles by asking “What parameter is NOT part of your thrombosis risk factor profile?” Please access our December Quick Question on […]

read more

Comments (0)

Quick Question Archive

Nov 30 2022

george

November, 2022 Quick Question: PT/INR

The stem or our November 2022 Quick question asked, If you use the PT when no warfarin is being measured, how do you report the results? Our 51 participants responded as follows: Report both PT and INR: 34 [66%] Report PT/MRI ratio: 0 Report PT only: 14 [27%] Report INR only: 4 [7%] Answer 2 […]

read more

Comments (3)

Anticoagulant Therapy

Nov 30 2022

george

FDA Approves Gene Therapy for Hemophilia B

Click here for CSL Behring’s press release from November 22, 2022, announcing FDA approval of etranacogene dezaparvovec [Hemgenix] for adult Hemophilia B [factor IX deficient] patients.

read more

Comments (0)

Bleeding Disorders

Nov 17 2022

george

Ultracentrifuge Plasma?

Received 11-13-22: Hello, We have an ultracentrifuge in our lab that is used in our chemistry department for lipemic samples. In the coagulation department,

read more

Comments (0)

Anticoagulant Therapy

Nov 15 2022

george

The Dilute Thrombin Time Measures DTIs

Here is the abstract of a pre-publication release comparing direct thrombin inhibitor results from the plasma-diluted thrombin time [DTT] to the partial thromboplastin time [PTT]:

read more

Comments (0)

Anticoagulant Therapy

Nov 15 2022

george

Poster: a Handheld Fibrinogen Assay Device

The qLab FIB is a recently introduced handheld point-of-care device that returns a fibrinogen result within ten minutes using a single drop of citrated whole blood.

read more

Comments (0)

Factor Assays

Nov 9 2022

george

November, 2022 Quick Question

Please visit and respond to our November 2022 Quick Question, submitted by Dave McGlasson. The question asks, "If you use the PT when no warfarin is being measured, how do you

read more

Comments (0)

Blog